2019

1. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis

   Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1242-1248

2. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort

   Annals of the Rheumatic Diseases, Vol. 78, Núm. 5, pp. 648-656